TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
TVGN

Tevogen Bio Holdings Inc.

Healthcare · Biotechnology

7.90$ +0.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow TVGN
Line item 2022 2023 2024 2025 2026
– – – – –
– +2,361.6% +63.9% +6.7% +26.2%
– +686.2% -100.0% – -60.2%
– – – -101.9% –
– +336.6% -72.2% -100.0% –
– +336.6% -72.2% – –
– – – – –
– -100.0% – -75.0% +240.0%
– -40.0% -48.4% +215.8% -4.6%
– -123.0% – – -416.8%
– – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?